跳转至内容
Merck
CN
所有图片(2)

文件

安全信息

912298

Sigma-Aldrich

NanoFabTx microfluidic chip

for 10-30 μm particles

登录查看公司和协议定价

别名:
Microfluidic kit, Microparticle, NanoFabTx, Nanoformulation
UNSPSC代码:
41121800
NACRES:
NA.23

描述

Microfludic hardware kit component for synthesizing 10-30 μm microparticles

Kit components : Microfluidic chip x 1

质量水平

应用

advanced drug delivery

正在寻找类似产品? 访问 产品对比指南

一般描述

NanoFabTx microfluidic chip, for 10-30 μm particles is a component of our NanoFabTx microfluidic - micro, device kit for synthesis of 10-30 μm particles (911879). The kit additionally includes a protocol, supporting manifold, tubing, and additional accessories for microfluidic-based synthesis.

应用

NanoFabTx microfluidic chips precisely control and manipulate fluids on the microscale. Their well-controlled geometries enable facile syntheses of monodisperse polymeric microparticles. NanoFabTx microfluidic chip, for 10-30 μm particles particles can be used as a replacement for the component in our NanoFabTx microfluidic - micro, device kit for synthesis of 10-30 μm particles (911879).

法律信息

NANOFABTX is a trademark of Sigma-Aldrich Co. LLC

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Samar Damiati et al.
Genes, 9(2) (2018-02-22)
Microfluidic devices present unique advantages for the development of efficient drug carrier particles, cell-free protein synthesis systems, and rapid techniques for direct drug screening. Compared to bulk methods, by efficiently controlling the geometries of the fabricated chip and the flow
Xuanyu Li et al.
Advanced drug delivery reviews, 128, 101-114 (2017-12-27)
Microfluidic chips allow the rapid production of a library of nanoparticles (NPs) with distinct properties by changing the precursors and the flow rates, significantly decreasing the time for screening optimal formulation as carriers for drug delivery compared to conventional methods.
Andrew Gdowski et al.
Journal of nanobiotechnology, 16(1), 12-12 (2018-02-13)
The process of optimization and fabrication of nanoparticle synthesis for preclinical studies can be challenging and time consuming. Traditional small scale laboratory synthesis techniques suffer from batch to batch variability. Additionally, the parameters used in the original formulation must be

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门